Scientech Research LLC’s Abivax ABVX Stock Holding History

Scientech Research LLC’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,294	Closed	-$789K	–	483
2025 Q3	$789K	Buy	+9,294	New	+$570K	0.28%	102

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Scientech Research LLC's ABVX Position: Q4 2025 in Review

Scientech Research LLC sold out of Abivax (ABVX) in Q4 2025, closing a stake of 9,294 shares — an estimated $789K sold.

Scientech Research LLC first reported a position in ABVX in Q3 2025 and held it in 1 quarter. The position peaked at $789K in Q3 2025. 247 funds tracked by Wall St. Rank hold ABVX as of Q4 2025.

Scientech Research LLC reported no remaining Abivax position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 9,294 Abivax shares in Q4 2025, an estimated $789K.
Scientech Research LLC first reported a position in Abivax in Q3 2025 and held it in 1 quarter.
Scientech Research LLC's Abivax position peaked at $789K in Q3 2025.
247 funds tracked by Wall St. Rank held Abivax as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.